In resectable, locally advanced esophageal squamous cell carcinoma, neoadjuvant Tyvyt plus chemoradiotherapy led to an ...

Nicola Francis has had 20 operations since being born after she was diagnosed with a rare and aggressive tumour after falling ...

Data from the Phase 3 PALOMA-3 study showed non-inferiority to intravenous administration meeting both co-primary pharmacokinetic (PK) endpoints, as well as a five-fold reduction in infusion-related ...

A doctor at a local cancer institute hopes to do more clinical studies to see if lab findings apply to actual patients. Read more at straitstimes.com.

The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...

Financially, UroGen has a market cap of $464mn and a cash runway of 8-9 quarters, despite facing patent challenges from Teva.

Ovarian cancer is the deadliest gynecologic malignancy globally and is increasing in incidence and mortality with currently ...

A common aromatic shrub that has served as traditional medicine for centuries could point the way toward innovative treatments for colorectal cancer ...

The following is a summary of “Clinical significance and pro-oncogenic function of DBF4 in clear cell renal cell carcinoma,” published in the January 2025 issue of Urology by Chen et al. Clear cell ...

17 A safety monitoring committee reviewed data from the first six patients after completion of one cycle of open-label BV + Len + R in the safety run-in period ... Patients must have received ≥2 ...

Baseline geriatric assessment vulnerabilities and quality of life scores correlate with overall survival in patients with ...

Sintilimab plus neoadjuvant CRT improved pathological complete response rates in resectable, locally advanced ESCC, per phase ...